Jefferies Financial Group Inc. Grows Holdings in Elevance Health, Inc. $ELV

Jefferies Financial Group Inc. raised its position in Elevance Health, Inc. (NYSE:ELV) by 498.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 78,397 shares of the company’s stock after buying an additional 65,288 shares during the period. Jefferies Financial Group Inc.’s holdings in Elevance Health were worth $27,482,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Murphy Middleton Hinkle & Parker Inc. acquired a new stake in shares of Elevance Health in the fourth quarter valued at about $5,941,000. Evergreen Wealth Management LLC grew its position in shares of Elevance Health by 33.5% in the third quarter. Evergreen Wealth Management LLC now owns 17,283 shares of the company’s stock valued at $5,584,000 after purchasing an additional 4,336 shares during the period. Blume Capital Management Inc. grew its position in shares of Elevance Health by 236.7% in the third quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock valued at $1,986,000 after purchasing an additional 4,320 shares during the period. Victory Capital Management Inc. grew its position in shares of Elevance Health by 31.1% in the third quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after purchasing an additional 109,462 shares during the period. Finally, Caprock Group LLC acquired a new stake in shares of Elevance Health in the third quarter valued at about $1,638,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

ELV has been the topic of several research analyst reports. Truist Financial dropped their target price on shares of Elevance Health from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. UBS Group lifted their target price on shares of Elevance Health from $400.00 to $460.00 and gave the company a “buy” rating in a research report on Friday. Wall Street Zen lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Weiss Ratings upgraded shares of Elevance Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 18th. Finally, Citigroup upgraded shares of Elevance Health to a “buy” rating in a research report on Wednesday, April 29th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, Elevance Health presently has an average rating of “Moderate Buy” and a consensus price target of $399.32.

Elevance Health Stock Performance

ELV opened at $394.41 on Friday. The firm has a market capitalization of $85.65 billion, a PE ratio of 16.78, a PEG ratio of 2.23 and a beta of 0.66. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $408.00. The firm’s 50-day moving average price is $333.81 and its 200 day moving average price is $336.25. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The firm had revenue of $49.49 billion for the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. Elevance Health’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the business posted $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. As a group, sell-side analysts expect that Elevance Health, Inc. will post 26.91 EPS for the current fiscal year.

Elevance Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be given a dividend of $1.72 per share. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. Elevance Health’s payout ratio is presently 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.